William McCulloch

3.3k citations
88 papers · 2.5k · 3 hit papers · h-index 21

Impact in

    • Cutaneous lymphoproliferative disorders research
    • Cancer, Lipids, and Metabolism
    • Cancer, Hypoxia, and Metabolism

Papers in

    • Histone Deacetylase Inhibitors Research 13
    • Peroxisome Proliferator-Activated Receptors 7
    • Phytochemical compounds biological activities 6
    • Cancer, Lipids, and Metabolism 16
    • Cancer, Hypoxia, and Metabolism 13

William McCulloch

81 papers receiving 2.5k citations

William McCulloch's Hit Papers

Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2b trial 2024 · 55 citations
550+5+10Years since publication100200300400

Peers

William McCulloch
Comparison fields: 5 of 112
  • Dermatology 304
  • Cancer Research 500
  • Parasitology 165
  • Molecular Biology 1.3k
  • Oncology 416
Replace Stefan Schweyer with:
Stefan Schweyer Germany
Takashi Tanaka Japan
J Bréard France
Charles Perkins United States
J. S. Rhim United States
Edit Tarcsa United States
Peter J. Dawson United States
Anne M. Fourie United States
S. Jaharul Haque United States
Jun-ichi Furuyama Japan
William McCulloch relative to Stefan Schweyer Germany Stefan Schweyer's profile →
Citations per field
00.5×11×
Stefan Schweyer · 1×
Citations per year

Countries citing papers authored by William McCulloch

Since Specialization
Citations

This map shows the geographic impact of William McCulloch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William McCulloch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William McCulloch more than expected).

Fields of papers citing papers by William McCulloch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William McCulloch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William McCulloch. The network helps show where William McCulloch may publish in the future.

Co-authors

The 25 scholars most cited alongside William McCulloch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with William McCulloch Line = papers co-authored together William McCulloch links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma
Hit paper breakdown →
2010486
2 2011252
3 2021207
4
TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial
Hit paper breakdown →
2021168
5 2017155
6 2009151
7 2006128
8 201998
9
Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2b trial
Hit paper breakdown →
202455
10 199452
11 201244
12 201638
13 201235
14 199434
15 202129
16 201129
17 196626
18
An in vivo comparison of oral 5-iodo-2'-deoxyuridine and 5-iodo-2-pyrimidinone-2'-deoxyribose toxicity, pharmacokinetics, and DNA incorporation in athymic mouse tissues and the human colon cancer xenograft, HCT-116.
199424
19 201723
20 197123

About William McCulloch

William McCulloch is a scholar working on Molecular Biology, Cancer Research, Oncology, Parasitology and Dermatology, having authored 88 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (16 papers), Histone Deacetylase Inhibitors Research (13 papers), Cancer, Hypoxia, and Metabolism (13 papers), Leptospirosis research and findings (11 papers), Cutaneous lymphoproliferative disorders research (11 papers), Peroxisome Proliferator-Activated Receptors (7 papers), Peptidase Inhibition and Analysis (6 papers) and Phytochemical compounds biological activities (6 papers). The work is most often cited by research in Dermatology (304 citations), Cancer Research (500 citations), Parasitology (165 citations), Molecular Biology (1.3k citations) and Oncology (416 citations). William McCulloch has collaborated with scholars based in United States, United Kingdom and Poland. Frequent co-authors include Cedric J. Pearce, Nicholas H. Oberlies, Karen M. VanderMolen, George Kemble, Sean Whittaker, Tadeusz Robak, Marie O’Farrell, Madeleine Duvic, Adam Lerner and Youn H. Kim. Their work appears in journals such as Journal of Clinical Oncology, Blood, Cancer Research, Journal of the American Veterinary Medical Association and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact